Professional Documents
Culture Documents
GBD 2
GBD 2
• To ensure that all estimates and projections were derived on the basis of objective
epidemiological and demographic methods
• To measure the burden of disease using a metric that is a cost effective (DALY)
Burden of Disease Methodology
Developed for the 1990 Global Burden of Disease Study by WHO and
Harvard to confront data deficiencies in measuring population health
to guide investment in health
Explicit values:
- age weights,
- discounting,
- severity weights,
- expected life span
Global Trends in Mortality and Life Expectancy
• There was rapid progress in life expectancy from 1950 to 2017:
• Males, up from 48 years in 1950 to 71 years in 2017
• Females, up from 53 years in 1950 to 76 years in 2017
• Among age groups, the under-5 age group experienced huge reductions in mortality between
1950 and 2017, while adults have made much less progress, particularly adult males.
• While females tend to live longer than males, the gap in life expectancy between them varies
substantially by level of socioeconomic development.
52 years 60 70 80 85
Females tend to live longer than males
Total number of global deaths, 1950–2017
0 to 6 days
• The proportion of deaths in those over age 75 increased from 12%
7 to 27 days of total deaths in 1950 to 39% in 2017.
28 to 364
Numbers of deaths in millions
days
1 to 4
5 to 9 • There have been dramatic declines in under-5 mortality, but there
10 to 14 were
15 to 19 still 5.4 million deaths among children under 5 worldwide in 2017.
20 to 24
25 to 29
30 to 34
35 to 39 • Declines in under-5 mortality were fastest among
40 to 44
45 to 49 countries at the lowest level of Socio-demographic
Index (SDI)**
50 to 54
55 to 59
60 to 64
65 to 69
70 to 74
75 to 79
80 to 84
85 to 89
90 to 94
95 plus
Distribution of deaths by leading cause
groups
(males and females, world, 2004)
Leading causes of early death, 1990 and 2017
Ischemic heart disease, neonatal disorders, stroke, lower respiratory infections, diarrhea, road injuries, and chronic
obstructive pulmonary disease (COPD) accounted for more than 1 million deaths each worldwide in 2017
1990 2017
Communicable, maternal, neonatal, and nutritional
rank** rank
1 Ischemic heart disease diseases
2 Neonatal disorders
3 Stroke
Non-communicable diseases
4 Lower respiratory infections
Injuries
5 Diarrheal diseases
6 Road injuries
7 COPD
Same or increase Decrease
**
Ranking based on number of years
8 HIV/AIDS lived with disability (YLLs) at all
ages
9 Congenital birth defects
10 Malaria
10 Malaria
11 COPD 11 Tuberculosis
19 HIV/AIDS 39 Measles
Leading causes of disability, 1990 and 2017
201
7 Dietary iron deficiency 7
9 Diabetes
Extra years lived by females compared to males in good health versus poor
health 2017
Eastern Europe 29%
Central Asia 27%
Tropical Latin America 34%
Southern sub-Saharan Africa 34%
Central Europe 22%
Southeast Asia 32%
High-income Asia Pacific 44%
Central Latin America 33%
Southern Latin America 32%
East 42%
Asia 37%
Oceania 37%
Caribbean 30%
Eastern sub-Saharan Africa 49%
High-income North America 45%
North Africa and Middle 48%
East 41%
Western Europe 35%
Australasia 31%
Central sub-Saharan Africa 34%
Western sub-Saharan Africa 92%
Andean Latin America 0 4 12
South Asia 8
Extra years lived by females
• NCDs contribute to around 5.87 million deaths that account for 60 % of all deaths in India.
• India shares more than two-third of the total deaths due to NCDs in the South-East Asia Region (SEAR) of
WHO.
• The new national estimates for diabetes and other non-communicable diseases (NCD) shows that 31 million more Indians
became diabetic in four years (2019-2021).
• In 2021, a study found that India has 101 million people with diabetes and 136 million people with prediabetes. Diabetic
capital
• 213 million people had hypercholesterolaemia (wherein fat collects in arteries and puts individuals at greater risk of heart
attack and strokes).
• 185 million had high low-density lipoprotein (LDL) cholesterol.
The Socio-economic Burden of NCDs
US$ 170B
is the overall cost for
all developing
countries to scale up
US$ 7T
is the cumulative lost output
action by in developing countries
implementing a set of associated with NCDs between
"best buy" 2011-2025
interventions,
identified as priority
actions by WHO
Cancer
Diabetes Chronic
Respiratory
Diseases
Cardiovascular
Diseases
Other NCDs
Physical Unhealthy
inactivity diets
Tobacco Harmful use of Malnutrition
Obesity use alcohol
Projected deaths by cause and income (2004 to 2030)
WHO
30
Intentional injuries
Other unintentional
25
Road traffic accidents
Deaths (millions)
Other NCD
20
Cancers
15
10 CVD
Mat//peri/nutritional
5
Other infectious
HIV, TB, malaria
0
2004 2015 2030 2004 2015 2030 2004 2015 2030
High income Middle income Low income
Noncommunicable Diseases
Burden of disease in disability adjusted life years
(2004)
Noncommunicable Diseases
Global burden of disease attributable top 20 risk factors
Underweight
Unsafe sex
High blood pressure
Tobacco
Alcohol
0% 1% 2% 3% 4% 5% 6% 7% 8% 9% 10%
Smoking prevalence
Europe
Africa
0 2 4 6 8 10 12
Death rate per 1000 adults aged 15–59 years
• DALYs per 100,000 people of the population
• Total Health Expenditure per capita ranges between US$ 325 to 2750
• Includes
Better management of NCDs
detecting, screening is critical
and treating these diseases, and providing access to palliative care for
people in need.
40
35
30
25 1998
Percent
20
15 2005
10
5
0
Hi Upper Mdl Middle Low
Income level
• CVDs and other NCDs Will Further Widen the Health Gap between Rich and Poor
Countries
• There is risk that the progress made in slowing the HIV epidemic could be
reversed without a continued robust investment in health.
• People’s health can improve, but it demands attention, resources, action, and
continued prioritization of these drivers of health.
(reducing key risk factors, increasing educational attainment and income)